Is NPS Swasthya enough for medical emergencies? Here’s the reality

The buzz around NPS Swasthya has been hard to miss. Touted as a “game changer” for healthcare planning, many see it as a smart new way to manage medical costs. But beneath the excitement, experts are urging caution, especially for those thinking of replacing health insurance altogether.

Abhishek Kumar, Sebi RIA and founder of Sahaj Money, believes this growing perception could lead to serious mistakes.

IT’S NOT INSURANCE, IT’S YOUR OWN MONEY

At its core, NPS Swasthya does not work like a traditional health policy. There is no fixed cover that protects you beyond your savings.

Abhishek Kumar explains it simply: “This isn’t insurance. It’s your own money.”

Unlike a Rs 10 lakh health policy that pays the full insured amount during a claim, NPS Swasthya only allows you to use what you have contributed. If your corpus is Rs 1 lakh, that is your limit. Nothing more.

He adds, “That’s not protection, that’s a savings account with extra steps.”

THE MATHS BEHIND THE 25% RULE

The scheme allows partial withdrawals, but only up to 25% of your contribution. On paper, that may sound helpful. In reality, it may fall short.

Kumar explains, “You contribute Rs 25,000. You can access 25% = Rs 6,250. A single ICU day in a tier-1 hospital could cost Rs 40,000+. Your ‘medical safety net’ won’t cover one night.”

With rising hospital costs, this gap can quickly become a problem during emergencies.

A HIT TO YOUR RETIREMENT SAVINGS

Another issue is the long-term impact. Every withdrawal reduces your retirement corpus, which depends heavily on compounding over time.

Kumar warns, “Every rupee you pull out is a rupee not compounding for the next 25 years.”

He adds that withdrawing Rs 50,000 at the age of 35 could mean losing nearly Rs 5 lakh by retirement, due to missed compounding.

THE Rs 50,000 ENTRY BARRIER

There is also a minimum accumulation requirement before the health benefit can be used. For many households, especially those already dealing with medical expenses, reaching Rs 50,000 may take time.

Kumar highlights this concern, By the time the fund is usable, a regular Rs 10 lakh family floater could’ve already paid 3 claims.”

This delay can limit its usefulness for those who need immediate financial protection.

RISK OF A FALSE SENSE OF SECURITY

Perhaps the biggest risk, experts say, is psychological. Some people may feel financially protected simply because they have NPS Swasthya.

Kumar cautions, “‘I have NPS Swasthya, I don’t need health insurance.’ That sentence could trouble you the day you land in ICU with Rs 2 lakhs in the account and a Rs 12 lakh bill.”

Without adequate insurance, such gaps can lead to severe financial stress.

WHERE IT ACTUALLY FITS

Despite the concerns, experts do not dismiss the product entirely. Instead, they stress the importance of using it correctly.

Kumar says, “NPS Swasthya is useful only as the third layer of your financial plan.”

According to him, a basic health insurance policy should come first, followed by a higher cover through a super top-up. Only after that should NPS Swasthya be considered as an additional cushion.

In other words, NPS Swasthya can play a supporting role, but it is not a replacement for health insurance. Confusing the two could leave families exposed at the worst possible time.

As Kumar puts it, “The product isn’t bad. The marketing is misleading.”

Latest

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest

Paytm shares tumble 6% today: Is this dip a buying chance for investors?

Paytm shares fell 6% today. Is this panic-driven weakness, or a smart chance for investors to buy into the fintech stock at lower levels now?

Topics

AI era hiring: Rs 50,000 stipend, flexible roles, and real work from day 1

Newton School of Technology's latest placement cycle expanded from 10 roles to 11 as companies assessed candidates in real time. The shift highlighted growing d

Cursor AI Agent wipes out startup database in 9 seconds, founder shares 30-hour chaos timeline

A startup founder said Cursor AI Agent erased the company database in nine seconds. The account traced 30 hours of disruption after the incident.

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Reopen the Strait of Hormuz and end the war, Iran offers new proposal to US

Iran has reportedly offered a two-stage plan to US via intermediary Pakistan, which offers prolonged period of ceasefire extension or a permanent end to the war

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Watch out Apple and Samsung, OpenAI is making AI smartphone with agentic capabilities

OpenAI is reportedly working with MediaTek and Qualcomm on smartphone processors, aiming to build an AI-first device powered by agent-led experiences.

ICSE, ISC board results to be out this week? Here’s what CISCE official has to say

The Council for the Indian School Certificate Examinations (CISCE) will declare the much-awaited ICSE Class 10 and ISC Class 12 Results 2026 shortly. Officials

Sam Altman says Codex is causing major FOMO so he changing his sleep schedule

Sam Altman says GPT-5.5 in Codex is so good he’s cutting sleep. He has said due to AI he has switched to polyphasic sleep — a schedule involving multiple sh
spot_img

Related Articles

Popular Categories

spot_imgspot_img